(1 - 10 von 14
)
Viewpoint Molecular Targeting Appoints Frank Morich, M.D., Ph.D. to ...
www.finanznachrichten.de
... Inc.: Viewpoint Molecular Targeting Appoints Frank Morich, M.D., ... announced the appointment of Frank Morich, M.D., Ph.D., to its Board of Directors.
Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of
www.globenewswire.com
... autoimmune and chronic infectious diseases, announced today the addition of Frank Morich, M.D., Ph.D., to the Company's Board of Directors.
Christiaan De Wilde succeeds Frank Morich as Innogenetics' CEO
www.bionity.com
The Innogenetics Board of Directors has named Chief Financial Officer (CFO) Christiaan De Wilde as the company's Chief Executive Officer (CEO), following the
sortiert nach Relevanz / Datum